Page last updated: 2024-08-21

thiazoles and levodopa

thiazoles has been researched along with levodopa in 99 studies

Research

Studies (99)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	19 (19.19)	18.2507
2000's	67 (67.68)	29.6817
2010's	13 (13.13)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fernandes, MH; Pestana, M; Soares-da-Silva, P	1
Fernandes, MH; Soares-da-Silva, P	1
Pestana, M; Soares-da-Silva, P	1
Brannan, T; Prikhojan, A; Yahr, MD	1
Fernandes, MH; Soares-da-Silva, P; Vieira-Coelho, MA	1
Kołodziejczyk, K; Maj, J; Rogóz, Z; Skuza, G	1
Carvey, PM; Ling, ZD; Pieri, S	1
d'Agostini, F; Damsma, G; DaPrada, M; DeBoer, P; Heeringa, MJ	1
Fernandez, HH; Friedman, JH	1
Althaus, JS; Fici, GJ; VonVoigtlander, PF	1
Carvey, PM; Ling, ZD; Robie, HC; Tong, CW	1
Oertel, WH; Pinter, MM; Pogarell, O	1
Bennett, JP; Piercey, MF	1
Appel, SH; Jankovic, J; Le, W; Rowe, DB; Xie, W; Zou, L	1
Galiano, ML; Grandas, F	1
Arnold, G; Kupsch, A	1
Phillips, P	1
Weiner, WJ	1
Montastruc, JL; Rascol, O; Senard, JM	1
LeWitt, PA	1
Clarke C, E; Clarke J, A; Speller J, M	2
Anderson, WM; Gauger, L; Hauser, RA; Zesiewicz, TA	1
Cassel, W; Krüger, HP; Möller, JC; Oertel, WH; Peter, JH; Stiasny, K	1
Tanner, CM	1
Hebenstreit, E; Pinter, MM; Rutgers, AW	1
Sternon, J; Supiot, F; Zegers de Beyl, D	1
Archer, T; Fredriksson, A; Palomo, T	1
Agapito, C; Bhattacharya, KF; Chaudhuri, KR; Pal, S	1
Guttman, M; Houle, S; Hussey, D; Kish, S; Stewart, D; Wilson, A	1
Ball, J	1
Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A	1
Etminan, M; Rochon, PA; Samii, A; Takkouche, B	1
Adler, CH; Blasucci, L; Carvey, P; Caviness, JN; Chase, WM; Ferry, JJ; Goetz, CG; Kompoliti, K; Leibowitz, MT; Leurgans, S; Pincus, JH; Raman, R; Tan, E; Yones, LC	1
Azizi, E; Ostad, SN; Partovi, M; Sadeghein, A	1
Montgomery, EB	2
Jennings, D; Marek, K; Seibyl, J	1
Clarke, CE; Guttman, M	1
Quattrone, A; Zappia, M	1
Reichmann, H	1
Berardelli, A; De Pandis, MF; Modugno, N; Ruggieri, S; Stocchi, F; Thomas, A; Vacca, L; Valente, M	1
Bassi, A; Boffa, L; Brusa, L; Caramia, MD; Peppe, A; Pierantozzi, M; Ruggieri, S; Stanzione, P; Stefani, A	1
MacMahon, DG	1
Blackman, JA; Buck, ML; Conaway, MR; Patrick, PD	1
Morrish, PK	1
Bares, M; Dostál, V; Ehler, E; Fanfrdlová, Z; Fiedler, J; Klajblová, H; Kulist'ák, P; Rektor, I; Rektorová, I; Ressner, P; Svátová, J; Urbánek, K; Velísková, J	1
Albin, RL; Desmond, TJ; Frey, KA; Kemmerer, ES; Kilbourn, MR	1
Inzelberg, R; Nisipeanu, P; Schechtman, E	1
Barone, P	1
Lu, CS; Mok, V; Shan, DE; Tsoi, TH; Wong, KS; Yang, CC	1
Krahn, M; Lang, A; Marras, C; Naglie, G; Tomlinson, G	1
Jankovic, J; Le, W; Pan, T	1
Connemann, BJ; Schönfeldt-Lecuona, C	1
Kohno, Y; Takeuchi, S	1
Oertel, WH; Stiasny-Kolster, K	1
Alexander-Brown, B; Atassi, F; Barclay, L; Bennett, S; Berry, D; Biglan, K; Borchert, L; Brocht, A; Brown, D; Daigneault, S; DeAngelis, M; Dillon, S; Dobson, J; Evans, S; Factor, S; Fahn, S; Fontaine, D; Ford, B; Fussell, B; Hall, J; Hammerstad, J; Harrigan, M; Hodgeman, K; Holloway, RG; Hubble, J; Jankovic, J; Kamp, C; Kieburtz, K; Kurlan, R; Lang, A; LeWitt, P; Marek, K; McDermott, M; Miyasaki, J; Montgomery, A; Musch, B; O'Connell, C; Pahwa, R; Panisset, M; Pantella, C; Petsinger, G; Pfeiffer, B; Pfeiffer, R; Rainey, P; Rajput, A; Richard, K; Riley, D; Rodnitzky, R; Ross, T; Rost-Ruffner, E; Russell, DS; Seibyl, J; Shinaman, A; Shirley, T; Shoulson, I; Shults, C; Sime, E; Stacy, M; Standaert, D; Suchowersky, O; Sutherland, L; Tennis, M; Waters, C; Watts, A; Weeks, C; Weiner, W; Welsh, M; Wood, S; Wooten, F	1
Grosset, D; Grosset, K; Macphee, G; Needleman, F	1
Cassel, W; Haja, D; Körner, Y; Krüger, HP; Meindorfner, C; Möller, JC; Oertel, WH; Stiasny-Kolster, K	1
Bara-Jimenez, W; Chase, TN; Dimitrova, T; Favit, A; Mouradian, MM; Sherzai, A	1
Chen, SD; Chen, Y; Li, B; Liu, WG; Lu, GQ	1
Kurlan, R	1
Althoff, R; Jacobson, J; Martineau, RJ; Singh, A	1
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C	1
Bernauer, E; Finsterer, J	1
Bédard, PJ; Grégoire, L; Guidetti, P; Izzo, E; Rassoulpour, A; Samadi, P; Schwarcz, R	1
Asanuma, M; Diaz-Corrales, FJ; Miyazaki, I; Ogawa, N; Shimizu, M; Tanaka, K	1
Ahlskog, JE; Bower, JH; Josephs, KA; Klos, KJ; Matsumoto, JY	1
Schapira, AH	1
Dick, AW; Holloway, RG; Noyes, K	1
Brown, LA; Doan, J; Pellis, SM; Suchowersky, O; Whishaw, IQ	1
Bharmal, A; Lu, C; Suchowersky, O	1
Cenci, MA; Danysz, W; Dekundy, A; Pietraszek, M; Schaefer, D	1
Molnar, MZ; Mucsi, I; Novak, M	1
Chigir', IP; Fedorova, NV	1
Schindehütte, J; Trenkwalder, C	1
Kanzato, N; Murao, H; Nishihira, T; Takara, H	1
Baltazar, G; Duarte, EP; Saavedra, A	1
Bédard, PJ; Di Paolo, T; Grégoire, L; Guidetti, P; Izzo, E; Rassoulpour, A; Samadi, P; Schwarcz, R	1
Duggal, HS; Singh, I	1
Jin, CM; Lee, JJ; Lee, MK; Lim, SC; Yang, YJ	1
Danysz, W; Dekundy, A; Gravius, A; Morè, L; Nagel, J; Pietraszek, M	1
Almeida-Paes, R; Fialho Monteiro, PC; Frases, S; Gutierrez-Galhardo, MC; Nosanchuk, JD; Zancopé-Oliveira, RM	1
Di Paolo, T; Grégoire, L; Lévesque, D; Morissette, M; Ouattara, B; Rouillard, C; Samadi, P; Tamim, MK	1
Di Paolo, T; Gasparini, F; Gomez-Mancilla, B; Grégoire, L; Morin, N	1
Brotchie, JM; Fox, SH; Johnston, TH; McIldowie, MJ; Piggott, MJ	1
Auguet, M; Chabrier, PE; Ferrandis, E; Grandoulier, AS; Marin, JG; Mautino, G; Rocher, MN; Spinnewyn, B	1
Feng, LR; Maguire-Zeiss, KA	1
Konitsiotis, S; Maranis, S; Stamatis, D; Tsironis, C	1
Asanuma, M; Kikkawa, Y; Kimoto, N; Miyazaki, I; Miyoshi, K; Murakami, S; Takeshima, M	1
Gomperts, SN; Growdon, JH; Johnson, KA; Locascio, JJ; Marquie, M; Maye, J; Rentz, DM; Santarlasci, AL	1
Aron Badin, R; Auguet, M; Bertrand, A; Boulet, S; Brouillet, E; Chabrier, PE; Dollé, F; Gaillard, MC; Guillermier, M; Hantraye, P; Jan, C; Malgorn, C; Savasta, M; Spinnewyn, B; Van Camp, N	1
Di Paolo, T; Morissette, M; Parent, M; Riahi, G; Samadi, P	1
Bimpisidis, Z; Cenci, MA; Iderberg, H; Rylander, D	1
Fujita, M; Hagino, Y; Hashimoto, M; Ikeda, K; Kasai, S; Kobayashi, K; Meltzer, HY; Setogawa, S; Yamaura, H; Yanagihara, D	1
Ali, F; Josephs, KA	1

Reviews

20 review(s) available for thiazoles and levodopa

Article	Year
Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease. Journal of the neurological sciences, 1999, Feb-01, Volume: 163, Issue:1 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Humans; Levodopa; Motor Activity; Parkinson Disease; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles	1999
[Pramipexol: a new dopaminergic agonist for the treatment of Parkinson disease]. Neurologia (Barcelona, Spain), 1999, Volume: 14, Issue:5 Topics: Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Levodopa; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles; Treatment Outcome	1999
The initial treatment of Parkinson's disease should begin with levodopa. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Drug Therapy, Combination; Essential Tremor; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine; Thiazoles; Time Factors	1999
Treatment of Parkinson's disease should begin with a dopamine agonist. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5 Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles	1999
New drugs for the treatment of Parkinson's disease. Pharmacotherapy, 2000, Volume: 20, Issue:1 Pt 2 Topics: Antiparkinson Agents; Benzophenones; Benzothiazoles; Cabergoline; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Drug Synergism; Enzyme Inhibitors; Ergolines; Humans; Indoles; Levodopa; Nitrophenols; Parkinson Disease; Pramipexole; Thiazoles; Tolcapone	2000
Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:3 Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Tolerance; Humans; Levodopa; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles	2000
Pramipexole for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:3 Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dopamine Agonists; Humans; Levodopa; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles	2000
["Sleep attacks" in Parkinson patients. A side effect of nonergoline dopamine agonists or a class effect of dopamine agonists?]. Der Nervenarzt, 2000, Volume: 71, Issue:8 Topics: Accidents, Traffic; Automobile Driving; Benzothiazoles; Contraindications; Dopamine Agents; Dopamine Agonists; Germany; Humans; Indoles; Legislation, Drug; Levodopa; Narcolepsy; Parkinson Disease; Pramipexole; Thiazoles	2000
Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials. Drug safety, 2001, Volume: 24, Issue:11 Topics: Antiparkinson Agents; Benzothiazoles; Disorders of Excessive Somnolence; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; MEDLINE; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Risk Factors; Thiazoles	2001
Two advances in the management of Parkinson disease. Cleveland Clinic journal of medicine, 2002, Volume: 69, Issue:8 Topics: Age Factors; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dyskinesias; Electric Stimulation Therapy; Forecasting; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Risk Factors; Stereotaxic Techniques; Thiazoles	2002
DA agonists -- non-ergot derivatives: pramipexole: management of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17 Suppl 4 Topics: Benzothiazoles; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Pramipexole; Psychomotor Disorders; Randomized Controlled Trials as Topic; Thiazoles	2002
Do dopamine agonists or levodopa modify Parkinson's disease progression? European journal of neurology, 2002, Volume: 9 Suppl 3 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Carrier Proteins; Dihydroxyphenylalanine; Disease Progression; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; Indoles; Iodine Radioisotopes; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tropanes	2002
Dopamine agonist monotherapy in Parkinson's disease. Lancet (London, England), 2002, Nov-30, Volume: 360, Issue:9347 Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2002
Neuroprotection in idiopathic Parkinson's disease. Journal of neurology, 2002, Volume: 249 Suppl 3 Topics: Antiparkinson Agents; Benzothiazoles; Cell Death; Dopamine Agonists; Humans; Indoles; Levodopa; Neuroprotective Agents; Parkinson Disease; Pramipexole; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2002
Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison. Drugs & aging, 2003, Volume: 20, Issue:11 Topics: Age of Onset; Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Evidence-Based Medicine; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles	2003
Clinical strategies to prevent and delay motor complications. Neurology, 2003, Sep-23, Volume: 61, Issue:6 Suppl 3 Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Pramipexole; Thiazoles	2003
[Pharmacological profiles and clinical effects of antiparkinsonian agent, pramipexole]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2004, Volume: 123, Issue:6 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Pramipexole; Thiazoles	2004
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5 Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone	2005
Present and future drug treatment for Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:11 Topics: Benzothiazoles; Corpus Striatum; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Indans; Indoles; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; Psychomotor Performance; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Substantia Nigra; Thiazoles; Urinary Incontinence	2005
Management of restless legs syndrome in patients on dialysis. Drugs, 2006, Volume: 66, Issue:5 Topics: Amines; Anticonvulsants; Benzothiazoles; Clonazepam; Cyclohexanecarboxylic Acids; Dopamine Agents; Gabapentin; gamma-Aminobutyric Acid; Humans; Kidney Failure, Chronic; Levodopa; Narcotics; Pramipexole; Renal Dialysis; Restless Legs Syndrome; Thiazoles; Uremia	2006

Trials

19 trial(s) available for thiazoles and levodopa

Article	Year
Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study. Journal of neurology, neurosurgery, and psychiatry, 1999, Volume: 66, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles	1999
[Pramipexol: a new dopaminergic agonist for the treatment of Parkinson disease]. Neurologia (Barcelona, Spain), 1999, Volume: 14, Issue:5 Topics: Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Levodopa; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles; Treatment Outcome	1999
Pramipexole-induced somnolence and episodes of daytime sleep. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:4 Topics: Aged; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Narcolepsy; Parkinson Disease; Polysomnography; Pramipexole; Retrospective Studies; Thiazoles	2000
Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. JAMA, 2000, Oct-18, Volume: 284, Issue:15 Topics: Antiparkinson Agents; Benzothiazoles; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Double-Blind Method; Dyskinesias; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Proportional Hazards Models; Quality of Life; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed, Single-Photon	2000
An open-label, multicentre clinical trial to determine the levodopa dose-sparing capacity of pramipexole in patients with idiopathic Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:11 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles; Treatment Outcome	2000
Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD. Neurology, 2001, Jun-12, Volume: 56, Issue:11 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Receptors, Dopamine; Thiazoles; Tomography, Emission-Computed	2001
Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA, 2002, Apr-03, Volume: 287, Issue:13 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Brain; Cocaine; Disease Progression; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Degeneration; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Regression Analysis; Thiazoles; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2002
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. Neurology, 2002, May-14, Volume: 58, Issue:9 Topics: Aged; Antiparkinson Agents; Area Under Curve; Benzothiazoles; Biological Availability; Carbidopa; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Humans; Levodopa; Male; Parkinson Disease; Postmenopause; Pramipexole; Sex Factors; Thiazoles	2002
Combination of two different dopamine agonists in the management of Parkinson's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2002, Volume: 23 Suppl 2 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles; Treatment Outcome	2002
Pramipexole in comparison to l-dopa: a neuropsychological study. Journal of neural transmission (Vienna, Austria : 1996), 2003, Volume: 110, Issue:4 Topics: Aged; Analysis of Variance; Benzothiazoles; Cognition Disorders; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Thiazoles	2003
Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study. European journal of neurology, 2003, Volume: 10, Issue:4 Topics: Activities of Daily Living; Aged; Analysis of Variance; Antiparkinson Agents; Benzothiazoles; Cross-Over Studies; Depression; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Pergolide; Placebos; Pramipexole; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Single-Blind Method; Thiazoles; Treatment Outcome	2003
Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison. Drugs & aging, 2003, Volume: 20, Issue:11 Topics: Age of Onset; Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Evidence-Based Medicine; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles	2003
Efficacy, safety, and tolerability of pramipexole in untreated and levodopa-treated patients with Parkinson's disease. Journal of the neurological sciences, 2003, Dec-15, Volume: 216, Issue:1 Topics: Adult; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Female; Hong Kong; Humans; Levodopa; Male; Parkinson Disease; Pramipexole; Software Design; Taiwan; Thiazoles; Treatment Outcome	2003
Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:1 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Double-Blind Method; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Pain Measurement; Parkinson Disease; Pramipexole; Quality of Life; Thiazoles	2004
Low-dose pramipexole in the management of restless legs syndrome. An open label trial. Neuropsychobiology, 2004, Volume: 50, Issue:1 Topics: Administration, Oral; Aged; Antiparkinson Agents; Benzothiazoles; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Levodopa; Male; Middle Aged; Polysomnography; Pramipexole; Restless Legs Syndrome; Severity of Illness Index; Sleep Wake Disorders; Thiazoles; Treatment Outcome	2004
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Archives of neurology, 2004, Volume: 61, Issue:7 Topics: Aged; Benzothiazoles; Double-Blind Method; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Proportional Hazards Models; Quality of Life; Severity of Illness Index; Thiazoles	2004
Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:10 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pilot Projects; Pramipexole; Thiazoles	2004
Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness. PharmacoEconomics, 2005, Volume: 23, Issue:12 Topics: Administration, Oral; Adult; Antiparkinson Agents; Benzothiazoles; Cost-Benefit Analysis; Double-Blind Method; Female; Health Expenditures; Humans; Levodopa; Male; Parkinson Disease; Pramipexole; Prospective Studies; Reproducibility of Results; Sex Factors; Thiazoles; Time Factors; Treatment Outcome	2005
Motor deficits in Parkinsonian reaching: dopa-sensitivity influenced by real-world task constraint. Journal of motor behavior, 2006, Volume: 38, Issue:1 Topics: Activities of Daily Living; Aged; Amantadine; Antiparkinson Agents; Arm; Benzothiazoles; Biomechanical Phenomena; Carbidopa; Catechols; Dopamine Agents; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Movement; Nitriles; Parkinson Disease; Pramipexole; Thiazoles	2006

Other Studies

62 other study(ies) available for thiazoles and levodopa

Article	Year
Deamination of newly-formed dopamine in rat renal tissues. British journal of pharmacology, 1991, Volume: 102, Issue:3 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Deamination; Dopamine; In Vitro Techniques; Kidney; Levodopa; Male; Pargyline; Picolinic Acids; Rats; Rats, Wistar; Thiazoles	1991
Role of monoamine oxidase A and B in the deamination of newly-formed dopamine in the rat kidney. Journal of neural transmission. Supplementum, 1990, Volume: 32 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Deamination; Dopamine; In Vitro Techniques; Kidney; Levodopa; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Picolinic Acids; Rats; Rats, Inbred Strains; Thiazoles	1990
Effect of type A and B monoamine oxidase selective inhibition by Ro 41-1049 and Ro 19-6327 on dopamine outflow in rat kidney slices. British journal of pharmacology, 1994, Volume: 113, Issue:4 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benserazide; Dopamine; In Vitro Techniques; Isoenzymes; Kidney Cortex; Levodopa; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Picolinic Acids; Rats; Rats, Wistar; Thiazoles	1994
Effect of a selective MAO-A inhibitor (Ro 41-1049) on striatal L-dopa and dopamine metabolism: an in vivo study. Journal of neural transmission. Parkinson's disease and dementia section, 1994, Volume: 8, Issue:1-2 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catechols; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Levodopa; Male; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Thiazoles	1994
In vivo effects of the monoamine oxidase inhibitors Ro 41-1049 and Ro 19-6327 on the production and fate of renal dopamine. Journal of neural transmission. Supplementum, 1994, Volume: 41 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Kidney; Levodopa; Male; Monoamine Oxidase Inhibitors; Picolinic Acids; Rats; Rats, Wistar; Thiazoles; Tissue Distribution	1994
The behavioural effects of pramipexole, a novel dopamine receptor agonist. European journal of pharmacology, 1997, Apr-11, Volume: 324, Issue:1 Topics: Animals; Antiparkinson Agents; Benzazepines; Benzothiazoles; Body Temperature; Catalepsy; Clozapine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Haloperidol; Injections, Subcutaneous; Levodopa; Male; Mice; Motor Activity; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Spiperone; Stereotyped Behavior; Sulpiride; Thiazoles	1997
Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole. Journal of neural transmission (Vienna, Austria : 1996), 1997, Volume: 104, Issue:2-3 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Cell Count; Cell Survival; Culture Media, Conditioned; Dopamine Agonists; Female; Immunohistochemistry; Levodopa; Mesencephalon; Neurons; Pramipexole; Rats; Rats, Sprague-Dawley; Stereoisomerism; Thiazoles; Tyrosine 3-Monooxygenase	1997
Effect of monoamine oxidase A and B and of catechol-O-methyltransferase inhibition on L-DOPA-induced circling behavior. Journal of neural transmission (Vienna, Austria : 1996), 1997, Volume: 104, Issue:6-7 Topics: Animals; Antiparkinson Agents; Benzophenones; Catechol O-Methyltransferase Inhibitors; Enzyme Inhibitors; Levodopa; Male; Monoamine Oxidase Inhibitors; Motor Activity; Nitrophenols; Oxidopamine; Picolinic Acids; Rats; Rotation; Thiazoles; Tolcapone	1997
New anti-parkinsonian drugs. Medicine and health, Rhode Island, 1998, Volume: 81, Issue:7 Topics: Antiparkinson Agents; Benzophenones; Benzothiazoles; Humans; Indoles; Levodopa; Nitrophenols; Parkinson Disease; Pramipexole; Thiazoles; Tolcapone	1998
Pharmacological approaches to counter the toxicity of Dopa. Amino acids, 1998, Volume: 14, Issue:1-3 Topics: Animals; Benzothiazoles; Cells, Cultured; Cerebellum; Cytoplasmic Granules; Glutathione; Levodopa; Neuroprotective Agents; Pramipexole; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Selegiline; Thiazoles; Vitamin E	1998
Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:1 Topics: Animals; Antioxidants; Benzothiazoles; Cell Count; Cell Survival; Cells, Cultured; Culture Media, Conditioned; Dopamine Agents; Dopamine Agonists; Levodopa; Mesencephalon; Neuroprotective Agents; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles; Tyrosine 3-Monooxygenase; Vitamin E	1999
Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity. Life sciences, 1999, Volume: 64, Issue:15 Topics: Animals; Benzothiazoles; Cell Line; Cell Survival; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Glioma; Hybrid Cells; Kinetics; Levodopa; Neuroblastoma; Neuroprotective Agents; Pramipexole; Thiazoles	1999
[High dosage therapy of Parkinson disease. New dopamine agonist pramipexol allows reduction of L-dopa dose down to zero]. Der Nervenarzt, 1999, Volume: 70, Issue:8 Topics: Antiparkinson Agents; Benzothiazoles; Carbidopa; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pramipexole; Thiazoles	1999
Several classes of new drugs emerging for Parkinson disease. JAMA, 1999, Sep-08, Volume: 282, Issue:10 Topics: Antiparkinson Agents; Benzothiazoles; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine Agonists; Enzyme Inhibitors; Humans; Indoles; Levodopa; Nitriles; Parkinson Disease; Pramipexole; Thiazoles	1999
Dopamine agonists in early therapy for Parkinson disease: promise and problems. JAMA, 2000, Oct-18, Volume: 284, Issue:15 Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Pramipexole; Thiazoles	2000
[Dopaminergic agonists in the treatment of Parkinson's disease]. Revue medicale de Bruxelles, 2000, Volume: 21, Issue:6 Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles	2000
Effects of MAO inhibitors upon MPTP mice chronically treated with suprathreshold doses of L-dopa. Behavioural pharmacology, 2000, Volume: 11, Issue:7-8 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Clorgyline; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Levodopa; Locomotion; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Motor Activity; Phenelzine; Phenethylamines; Selegiline; Thiazoles; Tryptamines	2000
A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cabergoline; Disorders of Excessive Somnolence; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Retrospective Studies; Thiazoles	2001
Current advances in Parkinson's disease. Trends in neurosciences, 2001, Volume: 24, Issue:7 Topics: Antidepressive Agents; Antiparkinson Agents; Benzothiazoles; Brain Stem; Catechols; Depression; Dopamine Agonists; Humans; Levodopa; Nitriles; Parkinson Disease; Pramipexole; Selegiline; Thiazoles	2001
Efficacy and tolerability of dopamine agonists in a parkinsonian population. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:1 Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome	2001
Mitogenic effect of L-dopa on human periodontal ligament fibroblast cells. Journal of endodontics, 2002, Volume: 28, Issue:3 Topics: Cells, Cultured; Coloring Agents; Dopamine Agents; Fibroblasts; Humans; Levodopa; Mitosis; Periodontal Ligament; Tetrazolium Salts; Thiazoles; Tissue Preservation	2002
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. Neurology, 2002, Dec-24, Volume: 59, Issue:12 Topics: Antiparkinson Agents; Area Under Curve; Benzothiazoles; Biological Availability; Body Weight; Drug Interactions; Female; Humans; Levodopa; Male; Pramipexole; Sex Characteristics; Thiazoles	2002
The initial drug treatment of older patients with Parkinson's disease - consider an agonist, but don't demonise dopa. Age and ageing, 2003, Volume: 32, Issue:3 Topics: Antiparkinson Agents; Benzothiazoles; Catechol O-Methyltransferase; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Thiazoles	2003
The use of dopamine enhancing medications with children in low response states following brain injury. Brain injury, 2003, Volume: 17, Issue:6 Topics: Adolescent; Adult; Amantadine; Arousal; Awareness; Benzothiazoles; Brain Injuries; Bromocriptine; Child; Dopamine Agents; Dopamine Agonists; Female; Humans; Levodopa; Male; Methylphenidate; Neuropsychological Tests; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome; Unconsciousness	2003
REAL and CALM: what have we learned? Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:7 Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Corpus Striatum; Disease Progression; Dopamine; Feasibility Studies; Humans; Indoles; Levodopa; Neurons; Neuroprotective Agents; Parkinson Disease; Pramipexole; Putamen; Reference Values; Sensitivity and Specificity; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2003
Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole. Experimental neurology, 2003, Volume: 183, Issue:1 Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Autoradiography; Behavior, Animal; Benzothiazoles; Binding, Competitive; Corpus Striatum; Disease Models, Animal; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Neuropeptides; Oxidopamine; Parkinsonian Disorders; Pramipexole; Rats; Rats, Sprague-Dawley; Substantia Nigra; Thiazoles; Treatment Outcome; Tritium; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2003
Slowing Parkinson's disease progression: recent dopamine agonist trials. Neurology, 2004, Jan-27, Volume: 62, Issue:2 Topics: Antiparkinson Agents; Artifacts; Benzothiazoles; Clinical Trials as Topic; Disease Progression; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Pramipexole; Severity of Illness Index; Single-Blind Method; Thiazoles	2004
Slowing Parkinson's disease progression: recent dopamine agonist trials. Neurology, 2004, Jan-27, Volume: 62, Issue:2 Topics: Antiparkinson Agents; Benzothiazoles; Biological Transport; Cell Line, Tumor; Clinical Trials as Topic; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; In Vitro Techniques; Indoles; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuroblastoma; Parkinson Disease; Pramipexole; Thiazoles	2004
Ziprasidone in Parkinson's disease psychosis. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2004, Volume: 49, Issue:1 Topics: Aged; Antipsychotic Agents; Dopamine Agonists; Humans; Levodopa; Male; Parkinson Disease; Piperazines; Psychoses, Substance-Induced; Thiazoles	2004
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:11 Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles	2004
Predictors of sudden onset of sleep in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:11 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Comorbidity; Cross-Sectional Studies; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pramipexole; Risk Factors; Surveys and Questionnaires; Thiazoles	2004
Neuroprotection by pergolide against levodopa-induced cytotoxicity of neural stem cells. Neurochemical research, 2004, Volume: 29, Issue:12 Topics: Animals; Annexin A5; Antimetabolites; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Proliferation; Cell Survival; Cells, Cultured; Dopamine Agents; Flow Cytometry; Fluorescein-5-isothiocyanate; Levodopa; Mice; Neurons; Neuroprotective Agents; Pergolide; Stem Cells; Tetrazolium Salts; Thiazoles	2004
"Levodopa phobia": a new iatrogenic cause of disability in Parkinson disease. Neurology, 2005, Mar-08, Volume: 64, Issue:5 Topics: Aged; Amantadine; Benzothiazoles; Catechols; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Humans; Iatrogenic Disease; Indoles; Levodopa; Male; Middle Aged; Neurology; Neuropharmacology; Neurotoxicity Syndromes; Nitriles; Parkinson Disease; Pramipexole; Selegiline; Thiazoles; Treatment Outcome	2005
Pramipexole, ropinirole, and mania in Parkinson's disease. The American journal of psychiatry, 2005, Volume: 162, Issue:4 Topics: Adult; Antiparkinson Agents; Benzothiazoles; Bipolar Disorder; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles	2005
Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy. Metabolic brain disease, 2005, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; Antiparkinson Agents; Benzothiazoles; Brain; Chronic Disease; Dipeptides; Evoked Potentials, Visual; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Paromomycin; Pramipexole; Recovery of Function; Thiazoles; Treatment Outcome; Vision Disorders	2005
Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:7 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Kynurenic Acid; Kynurenine 3-Monooxygenase; Levodopa; Macaca fascicularis; Mixed Function Oxygenases; Motor Activity; Parkinsonian Disorders; Quinolinic Acid; Sulfonamides; Thiazoles; Time Factors	2005
Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro. Neurological research, 2005, Volume: 27, Issue:5 Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Antiparkinson Agents; Benzoquinones; Benzothiazoles; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Electron Spin Resonance Spectroscopy; Functional Laterality; Homovanillic Acid; Levodopa; Male; Mice; Mice, Inbred ICR; Oxidopamine; Parkinson Disease; Pramipexole; Thiazoles; Time Factors	2005
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism & related disorders, 2005, Volume: 11, Issue:6 Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Catechols; Databases, Factual; Dopamine Agonists; Humans; Indoles; Levodopa; Male; Mental Disorders; Middle Aged; Multiple System Atrophy; Nitriles; Parkinson Disease; Pramipexole; Sexual Dysfunctions, Psychological; Thiazoles	2005
Gambling and Parkinson disease. Archives of neurology, 2006, Volume: 63, Issue:2 Topics: Antiparkinson Agents; Benzothiazoles; Gambling; Humans; Levodopa; Parkinson Disease; Pramipexole; Risk Factors; Thiazoles	2006
Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease. Brain research bulletin, 2006, Apr-14, Volume: 69, Issue:3 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Catalepsy; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesias; Functional Laterality; Haloperidol; Levodopa; Male; Motor Activity; Oxidopamine; Parkinson Disease; Pyridines; Quinolines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Rotarod Performance Test; Thiazoles; Time Factors	2006
[Dopamine receptors agonists (mirapex) in the treatment of Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2006, Volume: 106, Issue:6 Topics: Anxiety; Benzothiazoles; Carbidopa; Delayed-Action Preparations; Depression; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Receptors, Dopamine D1; Thiazoles; Treatment Outcome	2006
Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing. Clinical neurology and neurosurgery, 2007, Volume: 109, Issue:2 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Laughter; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Piperazines; Psychoses, Substance-Induced; Quetiapine Fumarate; Thiazoles	2007
[Case of juvenile parkinsonism in pregnancy]. Rinsho shinkeigaku = Clinical neurology, 2006, Volume: 46, Issue:6 Topics: Adult; Antiparkinson Agents; Benzothiazoles; Cabergoline; Carbidopa; Contraindications; Dopamine Agents; Dopamine Agonists; Ergolines; Family Planning Services; Female; Humans; Infant, Newborn; Levodopa; Parkinsonian Disorders; Pramipexole; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Thiazoles	2006
Interleukin-1beta mediates GDNF up-regulation upon dopaminergic injury in ventral midbrain cell cultures. Neurobiology of disease, 2007, Volume: 25, Issue:1 Topics: Animals; Astrocytes; Blotting, Western; Cell Proliferation; Cell Survival; Cells, Cultured; Dopamine; Dopamine Agents; Enzyme-Linked Immunosorbent Assay; Glial Cell Line-Derived Neurotrophic Factor; Glial Fibrillary Acidic Protein; Hydrogen Peroxide; Immunohistochemistry; Interleukin-1beta; Levodopa; Mesencephalon; Neuroglia; Oxidants; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Up-Regulation; Ventral Tegmental Area	2007
Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys. Behavioural brain research, 2008, Jan-25, Volume: 186, Issue:2 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Drug Interactions; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Levodopa; Macaca fascicularis; Motor Activity; Parkinsonian Disorders; Quinolinic Acid; Sulfonamides; Thiazoles; Time Factors	2008
Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease. Progress in neuro-psychopharmacology & biological psychiatry, 2008, Feb-15, Volume: 32, Issue:2 Topics: Acute Disease; Antipsychotic Agents; Brief Psychiatric Rating Scale; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperazines; Psychoses, Substance-Induced; Thiazoles	2008
Effects of harman and norharman on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells. European journal of pharmacology, 2008, Jun-10, Volume: 587, Issue:1-3 Topics: Animals; Antiparkinson Agents; Apoptosis; Aromatic-L-Amino-Acid Decarboxylases; Blotting, Northern; Calcium; Carbolines; Cell Survival; Cyclic AMP; Dopamine; Flow Cytometry; Harmine; In Situ Nick-End Labeling; Levodopa; Membrane Potentials; Mitochondrial Membranes; PC12 Cells; Rats; RNA; Tetrazolium Salts; Thiazoles; Tyrosine 3-Monooxygenase	2008
Investigation on tolerance development to subchronic blockade of mGluR5 in models of learning, anxiety, and levodopa-induced dyskinesia in rats. Journal of neural transmission (Vienna, Austria : 1996), 2008, Volume: 115, Issue:12 Topics: Animals; Antiparkinson Agents; Anxiety Disorders; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Glutamic Acid; Learning Disabilities; Levodopa; Male; Maze Learning; Memory Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Synaptic Transmission; Thiazoles	2008
Growth conditions influence melanization of Brazilian clinical Sporothrix schenckii isolates. Microbes and infection, 2009, Volume: 11, Issue:5 Topics: Brazil; Culture Media; Hydrogen-Ion Concentration; Hyphae; Levodopa; Melanins; Naphthols; Pigments, Biological; Sporothrix; Temperature; Thiazoles; Time Factors	2009
Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides. Neuropharmacology, 2010, Volume: 58, Issue:1 Topics: Animals; Antiparkinson Agents; Benzoxazoles; Cocaine; Corpus Striatum; Disease Models, Animal; Docosahexaenoic Acids; Dopamine; Dopamine Uptake Inhibitors; Dynorphins; Dyskinesia, Drug-Induced; Enkephalins; Female; Iodine Isotopes; Levodopa; Macaca fascicularis; Naltrexone; Neuropeptides; Ovariectomy; Parkinsonian Disorders; Piperidines; Protein Precursors; RNA, Messenger; Sulfonamides; Tachykinins; Thiazoles; Time Factors	2010
Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys. Neuropharmacology, 2010, Volume: 58, Issue:7 Topics: Animals; Antiparkinson Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Levodopa; Locomotion; Macaca fascicularis; Parkinsonian Disorders; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome	2010
Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. The Journal of pharmacology and experimental therapeutics, 2010, Volume: 333, Issue:3 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Male; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Piperidines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Thiazoles	2010
BN82451 attenuates L-dopa-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. Neuropharmacology, 2011, Volume: 60, Issue:4 Topics: Animals; Area Under Curve; Behavior, Animal; Chromatography, High Pressure Liquid; Corpus Striatum; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Gene Expression; Levodopa; Male; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazoles	2011
Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance. Neurotoxicity research, 2011, Volume: 20, Issue:4 Topics: alpha-Synuclein; Analysis of Variance; Animals; Cell Line, Tumor; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Doxycycline; Drug Interactions; Gene Expression Regulation; Green Fluorescent Proteins; Heme Oxygenase-1; Herbicides; Humans; Levodopa; Membrane Potentials; Mice; Nerve Tissue Proteins; Neuroblastoma; Paraquat; Patch-Clamp Techniques; Permeability; Tetrazolium Salts; Thiazoles; Transfection; Tubulin; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins	2011
Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia. European journal of pharmacology, 2012, May-15, Volume: 683, Issue:1-3 Topics: Animals; Anti-Dyskinesia Agents; Disease Models, Animal; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Infusions, Intraventricular; Levodopa; Male; Oxidopamine; Phenols; Piperidines; Putamen; Quinoxalines; Rats; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Receptors, AMPA; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Substantia Nigra; Subthalamic Nucleus; Thiazoles	2012
Cyclooxygenase-independent neuroprotective effects of aspirin against dopamine quinone-induced neurotoxicity. Neurochemical research, 2012, Volume: 37, Issue:9 Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Aspirin; Cell-Free System; Cells, Cultured; Cyclooxygenase Inhibitors; Dopamine Agents; Dopaminergic Neurons; Glutathione; Indomethacin; Levodopa; Meloxicam; Methyldopa; Mice; Neurons; Neuroprotective Agents; Quinones; Sympatholytics; Thiazines; Thiazoles	2012
Brain amyloid and cognition in Lewy body diseases. Movement disorders : official journal of the Movement Disorder Society, 2012, Volume: 27, Issue:8 Topics: Aged; Amyloid beta-Peptides; Aniline Compounds; Antiparkinson Agents; Apolipoprotein E3; Cognition; Cognitive Dysfunction; Female; Genotype; Humans; Levodopa; Lewy Body Disease; Male; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Thiazoles	2012
IRC-082451, a novel multitargeting molecule, reduces L-DOPA-induced dyskinesias in MPTP Parkinsonian primates. PloS one, 2013, Volume: 8, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Antioxidants; Antiparkinson Agents; Behavior, Animal; Chromatography, High Pressure Liquid; Cyclooxygenase Inhibitors; Disease Models, Animal; Dopamine Agents; Dyskinesias; Immunohistochemistry; Levodopa; Macaca fascicularis; Magnetic Resonance Imaging; Male; Neurons; Oxidative Stress; Parkinson Disease; Positron-Emission Tomography; Thiazoles	2013
Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia. Biochemical pharmacology, 2013, Oct-01, Volume: 86, Issue:7 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Basal Ganglia; Behavior, Animal; Benzamides; Brain; Case-Control Studies; Dyskinesia, Drug-Induced; Levodopa; Macaca fascicularis; Parkinson Disease; Pyridines; Receptor, Serotonin, 5-HT1B; Serotonin; Sulfonamides; Thiazoles	2013
Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action. Experimental neurology, 2013, Volume: 250 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antiparkinson Agents; Dopamine Agonists; Drug Synergism; Dyskinesia, Drug-Induced; Levodopa; Parkinsonian Disorders; Pyridines; Rats; Receptor, Metabotropic Glutamate 5; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; Receptors, Dopamine D1; Serotonin Receptor Agonists; Thiazoles	2013
Involvement of cholinergic system in hyperactivity in dopamine-deficient mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Mar-13, Volume: 40, Issue:5 Topics: Acetylcholine; Akathisia, Drug-Induced; Animals; Anti-Dyskinesia Agents; Antipsychotic Agents; Central Nervous System Stimulants; Choline O-Acetyltransferase; Clozapine; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Extracellular Space; Haloperidol; Levodopa; Locomotion; Mice, Inbred C57BL; Piperazines; Psychomotor Agitation; Thiazoles	2015
Corticobasal degeneration: key emerging issues. Journal of neurology, 2018, Volume: 265, Issue:2 Topics: Aniline Compounds; Basal Ganglia; Carbolines; Cerebral Cortex; Dopamine Agents; History, 20th Century; Humans; Levodopa; Neurodegenerative Diseases; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Thiazoles	2018